Richard Scott Struthers - President & CEO, Director at Crinetics Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President & CEO, Director
Stock Symbol
CRNX on Nasdaq
All Insider Reports
All Insider Reports

Richard Scott Struthers - trading volume in the past year for Crinetics Pharmaceuticals, Inc.

Holdings reported by Richard Scott Struthers for Crinetics Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 661K $19.4M $29.40 26 Sep 2025 By Family Trust 1
Common Stock 320K $9.41M $29.40 26 Sep 2025 Direct
Common Stock 106K $4.77M $45.00 26 Sep 2025 By Family Trust 2
Common Stock 110K $3.23M $29.40 26 Sep 2025 By Family Trust 3
Common Stock 100K $2.94M $29.40 26 Sep 2025 By Family Trust 4
Common Stock 1K $29.4K $29.40 26 Sep 2025 By Spouse
Stock Option (Right to Buy) 0 02 Apr 2025 Direct Common Stock

Transactions reported by Richard Scott Struthers for Crinetics Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.